BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26851234)

  • 1. A Computational Modeling Approach for Deriving Biomarkers to Predict Cancer Risk in Premalignant Disease.
    Dhawan A; Graham TA; Fletcher AG
    Cancer Prev Res (Phila); 2016 Apr; 9(4):283-95. PubMed ID: 26851234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial Measures of Genetic Heterogeneity During Carcinogenesis.
    Storey K; Ryser MD; Leder K; Foo J
    Bull Math Biol; 2017 Feb; 79(2):237-276. PubMed ID: 27905065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TOP2A/MCM2, p16
    Del Moral-Hernández O; Hernández-Sotelo D; Alarcón-Romero LDC; Mendoza-Catalán MA; Flores-Alfaro E; Castro-Coronel Y; Ortiz-Ortiz J; Leyva-Vázquez MA; Ortuño-Pineda C; Castro-Mora W; Illades-Aguiar B
    BMC Cancer; 2021 Jan; 21(1):39. PubMed ID: 33413211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and Quantification of MicroRNAs from Human Saliva.
    Arunachalam SR; Tang KD; Punyadeera C
    Methods Mol Biol; 2019; 2054():105-114. PubMed ID: 31482450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1995; 23():1-9. PubMed ID: 8747372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for colitis-associated colorectal cancer.
    Chen R; Lai LA; Brentnall TA; Pan S
    World J Gastroenterol; 2016 Sep; 22(35):7882-91. PubMed ID: 27672285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premalignant breast lesions: role for biological markers in predicting progression to cancer.
    Stoll BA
    Eur J Cancer; 1999 May; 35(5):693-7. PubMed ID: 10505026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen and premalignant change: implications for early detection.
    Brawer MK; Lange PH
    CA Cancer J Clin; 1989; 39(6):361-75. PubMed ID: 2482117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can monoclonal antibody staining by 323/A3 and Ca1 of benign breast biopsies predict the development of breast cancer?
    Courtney SP; Williams S; Mansel RE
    J Cancer Res Clin Oncol; 1993; 119(3):127-30. PubMed ID: 8418084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Candidate Biomarkers of Non-Small Cell Lung Cancer Are Screened and Identified in Premalignant Lung Lesions.
    Nan Y; Du J; Ma L; Jiang H; Jin F; Yang S
    Technol Cancer Res Treat; 2017 Feb; 16(1):66-74. PubMed ID: 26809240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal expansions and short telomeres are associated with neoplasia in early-onset, but not late-onset, ulcerative colitis.
    Salk JJ; Bansal A; Lai LA; Crispin DA; Ussakli CH; Horwitz MS; Bronner MP; Brentnall TA; Loeb LA; Rabinovitch PS; Risques RA
    Inflamm Bowel Dis; 2013 Nov; 19(12):2593-602. PubMed ID: 24097228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate biomarkers of precancer and their application in chemoprevention.
    Kelloff GJ; Malone WF; Boone CW; Steele VE; Doody LA
    J Cell Biochem Suppl; 1992; 16G():15-21. PubMed ID: 1469895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biomarkers added to image-enhanced endoscopic imaging: will they further improve diagnostic accuracy?
    Krishnamoorthi R; Iyer PG
    Best Pract Res Clin Gastroenterol; 2015 Aug; 29(4):561-73. PubMed ID: 26381302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection: Spotting the first signs.
    Savage N
    Nature; 2011 Mar; 471(7339):S14-5. PubMed ID: 21430712
    [No Abstract]   [Full Text] [Related]  

  • 16. Genomic approaches to accelerate cancer interception.
    Beane J; Campbell JD; Lel J; Vick J; Spira A
    Lancet Oncol; 2017 Aug; 18(8):e494-e502. PubMed ID: 28759388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming Cancer Prevention through Precision Medicine and Immune-oncology.
    Kensler TW; Spira A; Garber JE; Szabo E; Lee JJ; Dong Z; Dannenberg AJ; Hait WN; Blackburn E; Davidson NE; Foti M; Lippman SM
    Cancer Prev Res (Phila); 2016 Jan; 9(1):2-10. PubMed ID: 26744449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
    Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in chemoprevention of cancer.
    Hong WK; Sporn MB
    Science; 1997 Nov; 278(5340):1073-7. PubMed ID: 9353183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse reflectance spectroscopy detects increased hemoglobin concentration and decreased oxygenation during colon carcinogenesis from normal to malignant tumors.
    Wang HW; Jiang JK; Lin CH; Lin JK; Huang GJ; Yu JS
    Opt Express; 2009 Feb; 17(4):2805-17. PubMed ID: 19219185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.